Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

4. Finance Expense

Underlying2012
£'000
2011
£'000
Finance expense arising from:
— Financial liabilities at amortised cost2,9443,898
— Interest cost in relation to employee benefit obligations12
— Foreign exchange losses898
Underlying finance expense3,8543,898
Non-underlying2012
£'000
2011
£'000
Loss on extinguishment of debt1581,256
Unwinding of discounts on deferred and contingent consideration277194
Non-underlying finance expense4351,450
Total finance expense4,2895,348

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.